Skip NavigationSkip to Content
NCI HeaderNational Cancer InstituteU.S. National Institutes of Healthwww.cancer.gov

Dr. Jordan L. Meier



Dr. Jordan L. Meier
Chemical Genomics
301-846-1929

Research Summary

Cofactor-Based Profiling of Chromatin Modifiers
Enzyme cofactors link cellular metabolism with the regulation of genome function through the activity of chromatin-modifying enzymes. A major focus of the laboratory is to integrate cofactor-based synthetic probes with high-throughput approaches for the proteomic, genomic, and structural characterization of chromatin modifiers. The goal of these studies is to expand the pharmacological map of epigenomic regulators involved in cancer, and to generate new knowledge for structure-based design, screening, and inhibitor development efforts.

Metabolic Regulation of Epigenetic Signaling
Recent studies have shown that many enzymes active in epigenetic mechanisms of genomic regulation are sensitive to the metabolic state of the cell. A second major aim of the lab is to understand the mechanisms by which metabolic perturbations influence genomic signaling mediated by chromatin modifying enzymes. Long term goals of this work include: 1) the discovery of biological mechanisms underlying oncometabolite-driven cancers, 2) the development of new diagnostics for cancers driven by metabolic mutations, and 3) the identification of small molecules which inhibit epigenetic modifications through metabolic disruption.
Publications
1 - 5 of 25 results

1)  Montgomery DC, Sorum AW, Meier JL.
Chemoproteomic Profiling of Lysine Acetyltransferases Highlights an Expanded Landscape of Catalytic Acetylation.
J. Am. Chem. Soc. 2014. [Journal]

2)  Meier JL.
Metabolic Mechanisms of Epigenetic Regulation.
ACS Chem. Biol. 8: 2607-2621, 2013. [Journal]

3)  Kang JS, Meier JL, Dervan PB.
Design of sequence-specific DNA binding molecules for DNA methyltransferase inhibition.
J. Am. Chem. Soc. 136: 3687-94, 2014. [Journal]

4)  Meier JL, Yu AS, Korf I, Segal DJ, Dervan PB.
Guiding the Design of Synthetic DNA-Binding Molecules with Massively Parallel Sequencing.
J. Am. Chem. Soc. 134: 17814-22, 2012. [Journal]

5)  Meier JL, Mercer AC, Rivera H, Burkart MD.
Synthesis and evaluation of bioorthogonal pantetheine analogues for in vivo protein modification.
J. Am. Chem. Soc. 128: 12174-84, 2006. [Journal]

Home | Contact Us | Policies | Accessibility | Viewing Files | Search | CCR - For Our Staff

A service of the National Cancer Institute

National Cancer InstituteNational Institutes of HealthHealth and Human ServicesUSA Gov - Official Web Portal